A summary of monoclonal antibody-enzyme/prodrug
- 1 December 1996
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 22 (3) , 341-349
- https://doi.org/10.1016/s0169-409x(96)00445-0
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Poly(ethylene glycol)-Doxorubicin Conjugates Containing .beta.-Lactamase-Sensitive LinkersBioconjugate Chemistry, 1995
- Antibody-Directed Enzyme Prodrug TherapyClinical Immunotherapeutics, 1995
- Sulfated etoposide and nitrogen mustard prodrugs and their activation by streptomyces arylsulfataseDrug Delivery, 1995
- Self-Immolative Prodrugs: Candidates for Antibody-Directed Enzyme Prodrug Therapy in Conjunction with a Nitroreductase EnzymeJournal of Medicinal Chemistry, 1994
- Generation of cytotoxic agents by targeted enzymesBioconjugate Chemistry, 1993
- Analysis of a conjugate between anti-carcinoembryonic antigen monoclonal antibody and alkaline phosphatase for specific activation of the prodrug etoposide phosphateCancer Immunology, Immunotherapy, 1992
- Preparation and characterization of a .beta.-lactamase-Fab' conjugate for the site-specific activation of oncolytic agentsBioconjugate Chemistry, 1992
- A novel targeted delivery system utilizing a cephalosporin-oncolytic prodrug activated by an antibody β-lactamase conjugate for the treatment of cancerBioorganic & Medicinal Chemistry Letters, 1991
- Ablation of human choriocarcinoma xenografts in nude mice by antibody-directed enzyme prodrug therapy (ADEPT) with three novel compoundsEuropean Journal of Cancer and Clinical Oncology, 1991
- Antibody-penicillin-V-amidase conjugates kill antigen-positive tumor cells when combined with doxorubicin phenoxyacetamideCancer Immunology, Immunotherapy, 1990